Literature DB >> 6244010

Partial inhibition by lithium of the epinephrine-stimulated rise in plasma cyclic GMP in humans.

R H Belmaker, M Kon, R P Ebstein, H Dasberg.   

Abstract

Lithium-treated and drug-free individuals were each given 0.5 mg epinephrine subcutaneously and blood samples withdrawn for measurement of plasma cyclic AMP and cyclic GMP. The rise in plasma cyclic GMP in response to epinephrine was found to be partially inhibited by lithium treatment, and previous reports of lithium inhibition of the plasma cyclic AMP rise were replicated. Effects of lithium on cyclic AMP and cyclic GMP may relate to lithium's biphasic efficacy in depression and mania.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244010

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  2 in total

1.  Therapeutic concentrations of lithium and carbamazepine inhibit cGMP accumulation in human lymphocytes. A clinical model for a possible common mechanism of action?

Authors:  T Schubert; L Stoll; W E Müller
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression.

Authors:  B Lerer; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.